• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Catholic Review

Catholic Review

Inspiring the Archdiocese of Baltimore

Menu
  • Home
  • News
        • Local News
        • World News
        • Vatican News
        • Obituaries
        • Featured Video
        • En Español
        • Sports News
        • Official Clergy Assignments
        • Schools News
  • Commentary
        • Contributors
          • Question Corner
          • George Weigel
          • Elizabeth Scalia
          • Michael R. Heinlein
          • Effie Caldarola
          • Guest Commentary
        • CR Columnists
          • Archbishop William E. Lori
          • Rita Buettner
          • Christopher Gunty
          • George Matysek Jr.
          • Mark Viviano
          • Father Joseph Breighner
          • Father Collin Poston
          • Amen Columns
  • Entertainment
        • Events
        • Movie & Television Reviews
        • Arts & Culture
        • Books
        • Recipes
  • About Us
        • Contact Us
        • Our History
        • Meet Our Staff
        • Photos to own
        • Shop
        • CR Media platforms
        • Electronic Edition
        • Subscribe
  • Advertising
  • Shop
        • Purchase Photos
        • Books/CDs/Prayer Cards
        • Magazine Subscriptions
        • Archdiocesan Directory
  • Radio/Podcasts
        • Catholic Review Radio
        • Protagonistas de Fe
        • In God’s Image
  • News Tips
  • Subscribe
Pro-life activists hold a prayer vigil and news conference to call for the U.S. Supreme Court justices to "affirm the decision of Federal District Court Judge Matthew Kacsmaryk who suspended the Food and Drug Administration's approval of Mifepristone," in front of the Supreme Court in Washington April 21, 2023. (OSV News photo/Nathan Howard, Reuters)

Poll shows a majority of Americans say abortion drug should stay on market

May 10, 2023
By Kate Scanlon
OSV News
Filed Under: Feature, News, Respect Life, World News

WASHINGTON (OSV News) — A majority of Americans say the abortion drug mifepristone should remain on the market in the U.S., according to a Washington Post-ABC News poll, as the drug remains at the center of an ongoing legal battle.

The poll found that 66 percent of U.S. adults said mifepristone should remain on the market, while 24 percent said it should be taken off. Just under half — 47 percent — said access to mifepristone should remain status quo; while 12 percent say it should remain on the market but with additional restrictions in place, while 11 percent offered no opinion.

The U.S. Supreme Court said April 21 it would block a lower court’s restrictions on an abortion pill, leaving the drug on the market while litigation over the drug proceeds. The high court froze a lower court’s ruling to stay the U.S. Food and Drug Administration’s approval of the drug. The Justice Department and Danco Laboratories, a pharmaceutical company that manufactures the abortion pill mifepristone, previously asked the U.S. Supreme Court to intervene in the case after an appeals court allowed portions of an earlier ruling by U.S. District Judge Matthew Kacsmaryk in Texas to take effect.

Mifepristone, the first medication in a medical abortion, is prepared for a patient at Alamo Women’s Clinic in Carbondale, Ill., April 20, 2023. A majority of Americans say the abortion drug mifepristone should remain on the market in the U.S., according to a new Washington Post-ABC News poll. (OSV News photo/Evelyn Hockstein, Reuters)

A coalition of pro-life opponents of mifepristone, the first of two drugs used in a medication or chemical abortion, had filed suit in an effort to revoke the FDA’s approval of the drug, arguing the government acted in violation of its own safety standards when it first approved the drug in 2000. But proponents argued mifepristone poses statistically little risk to women using it for abortion early in pregnancy, and claim the drug is being singled out for political reasons. A study by the Guttmacher Institute, which supports legal abortion, found that more than half of U.S. abortions in 2020 were medication abortions.

The Supreme Court’s decision maintains the status quo for the drug while the case plays out.

But Kristi Hamrick, vice president of media and policy for Students for Life Action, found cause for optimism in the results of the new poll, telling OSV News that “if you break down the poll, the concerns over chemical abortion pills are growing.”

“When Students for Life first prioritized chemical abortion pills, people knew little about them and couldn’t see the threat to young women,” Hamrick said. “Today, that poll says that less than half want the pills on the market while a large number want them gone or restricted.”

Hamrick argued that even those who are pro-abortion could still have concerns about an “online, no-test distribution of a deadly cocktail that exposes women to injury, infertility, death, and abusers,” which she said is “worrying more and more women.”

An April poll conducted by CRC Research for Susan B. Anthony Pro-Life America found that “62 percent feel not very confident (26 percent) or not at all confident (35 percent) in the claim that the abortion pill is safe after being on the market for two decades, when they know that the FDA tracks no side effects other than death,” the pro-life group said.

Also in April, GenBioPro, which makes the generic version of mifepristone, sued the FDA seeking to block it from complying if the courts ultimately pull the drug off the market, an additional layer to the case.

Additional lawsuits in other states may also impact whether the drug remains available as well. Washington State has sought to block the Texas ruling. GenBioPro has also sued West Virginia over its state ban on mifepristone, arguing it violates the commerce clause of the Constitution.

The Supreme Court’s action returned the case to the 5th U.S. Circuit Court of Appeals, which is scheduled to hear arguments on May 17.

Read More Respect Life

Supreme Court hits brakes on court ruling that blocked abortion pill distribution by mail

Appeals court temporarily blocks policy permitting distribution of abortion pill by mail

Supreme Court rules New Jersey pregnancy centers can challenge state probe in federal court

Virginians march against extreme abortion amendment ‘seeking to devour life’

Canadian cardinal urges vote to stop expansion of assisted suicide to those with mental illness

Pope Leo encourages death penalty abolitionists as US brings back firing squad and electric chair

Copyright © 2023 OSV News

Print Print

Primary Sidebar

Kate Scanlon

Click here to view all posts from this author

For the latest news delivered twice a week via email or text message, sign up to receive our free enewsletter.

| MOST POPULAR |

  • Archbishop Lori announces associate pastor and deacon appointments
  • Meet the permanent deacons to be ordained May 9 at the Cathedral of Mary Our Queen
  • Archdiocesan staff celebrates Archbishop Lori’s 75th birthday
  • UFOs, extraterrestrial life explored at Vatican parish event
  • Catholic Charities new intergenerational center provides varied community services

| Latest Local News |

Archdiocesan staff celebrates Archbishop Lori’s 75th birthday

Knott Scholars recognized

A seagull on the Sistine Chapel inspires a story about being loved as you are

Young Catholic missionaries bring hope to Baltimore’s homeless population

Renewal underway at Baltimore Basilica

| Latest World News |

Israeli soldier photographed desecrating Mary statue in Lebanon

Leo XIV: A pope of order for chaotic times

‘My soul magnifies the Lord!’: Pope Leo marks anniversary of election at Marian shrine in Pompeii

Customer service story of ‘relatable’ Pope Leo XIV gone viral resonates with everyday people

One year in, Pope Leo navigates division through dialogue in his push for peace

| Catholic Review Radio |

Footer

Our Vision

Real Life. Real Faith. 

Catholic Review Media communicates the Gospel and its impact on people’s lives in the Archdiocese of Baltimore and beyond.

Our Mission

Catholic Review Media provides intergenerational communications that inform, teach, inspire and engage Catholics and all of good will in the mission of Christ through diverse forms of media.

Contact

Catholic Review
320 Cathedral Street
Baltimore, MD 21201
443-524-3150
mail@CatholicReview.org

 

Social Media

  • Facebook
  • Instagram
  • Twitter
  • YouTube

Recent

  • Dorothy Day: Catholic Worker founder pioneered a faith-based alternative to secularist progressivism
  • The Mom Friends You Need
  • Archdiocesan staff celebrates Archbishop Lori’s 75th birthday
  • Israeli soldier photographed desecrating Mary statue in Lebanon
  • Leo XIV: A pope of order for chaotic times
  • ‘My soul magnifies the Lord!’: Pope Leo marks anniversary of election at Marian shrine in Pompeii
  • Customer service story of ‘relatable’ Pope Leo XIV gone viral resonates with everyday people
  • One year in, Pope Leo navigates division through dialogue in his push for peace
  • Knott Scholars recognized

Search

Membership

Catholic Media Assocation

Maryland-Delaware-DC Press Association

The Associated Church Press

© 2026 CATHOLIC REVIEW MEDIA, ALL RIGHTS RESERVED